MIRACLE - art photonics

Latest News

21 February 2025

By Stanislav Perevoschikov

At art photonics GmbH, we're excited to share our latest Technical Note that delves deep into the fascinating world of Attenuated Total Reflectance (ATR) spectroscopy, offering remote access to your process. What Are ATR Fiber Probes? ATR Fiber Probes are specialized devices used for spectroscopic analysis from the UV to mid-IR regions. They enable real-time […]

7 February 2025

Is Your Industrial Process Falling Behind? 5 Signs You Need In-Line Spectroscopy

By Stanislav Perevoschikov

Are outdated sampling methods delaying decisions and increasing costs in your operations? art photonics outlines five critical indicators that it's time to integrate in-line spectroscopy into your process control strategy. 1. Frequent Batch Failures Without Clear ExplanationTraditional lab testing often misses real-time fluctuations that lead to batch failures.Our Solution: FlexiSpec Probes deliver instant chemical analysis […]

Latest Events

17 February 2025

APE 2025 | 26 February 2025, Marina Bay Sands, Singapore

By Stanislav Perevoschikov

art photonics is proud to announce that our Founder & Senior Adviser, Viacheslav Artyushenko, will open the EPIC TechWatch conference at Asia Photonics Expo 2025. His presentation, "Innovative Fiber Solutions for Life Photonics in 0.3-16µm Range," is scheduled for 26 February 2025 at Marina Bay Sands in Singapore. We extend our sincere thanks to Asia […]

28 January 2025

Day 1 at Photonics West 2025!

By Stanislav Perevoschikov

art photonics GmbH is happy to kick off Photonics West 2025 at Booth #1740! We’re showcasing our broad spectra fiber solutions in collaboration with our colleagues from NLIR, all under the Nynomic AG umbrella. What can you expect? Together, we’re offering cutting-edge tools to address your most challenging applications in infrared spectroscopy and industrial process […]

MIRACLE: Mid-infrared arthroscopy innovative imaging system for real-time clinical in depth examination and diagnosis of degenerative joint diseases

MIRACLE will push towards commercialisation the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage enabling early diagnosis of degenerative joint diseases such as osteoarthritis (OA). The proposed device is intended for use during arthroscopy, a minimally invasive surgery. Currently, the surgeon’s decision-making is based on visual inspection and manual probing of the cartilage tissue which is highly subjective and of poor repeatability. MIRACLE concept is to assess changes to the biochemical composition of articular cartilage, which precede OA. This will be achieved combining three novel photonics components: (i) a quantum cascade laser array tailored to biodiagnostics, (ii) an on-chip beam combiner for efficient radiation coupling, and (iii) a MIR sensing probe for imaging. These components will be integrated in a medical device to be placed in the arthroscopy market. In addition, to add value to the European medical equipment industry, MIRACLE strives towards cost reduction of OA patients contributing to more affordable public healthcare and promoting well-being in the European ageing population.

art photonics‘ role in joint work will be to develop and provide flexible IR-fibers for quantum cascade lasers (QCL) coupling with the distal end of arthroscopic probe.

The unique polycrystalline fiber technology for 4-16µm range and unique design of ATR-diamond tip will enable efficient and flexible coupling of QCL with detector. This worldwide first prototype of IR-fiber spectral sensor will open the first opportunity to see molecular changes in cartilage composition in-vivo, to link them with its specific decease and find the best way of the related treatment for a fast cartilage recovery.

This project received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 780598. The project is an initiative of the Photonics Public Private Partnership.